Drug intelligence / Profile preview

Melano TX

Development stage
Unknown
Lead developer
La Pristine Bioceuticals
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Melano TX is a dermatological product line developed by La Pristine Bioceuticals, primarily indicated for the treatment of melasma and other hyperpigmentation disorders. The product is available in both topical and oral formulations. The **Melano TX Cream** is a combination therapy containing **tranexamic acid**, **kojic acid**, **arbutin**, **magnesium ascorbyl phosphate**, and **vitamin E**. Tranexamic acid acts as a plasminogen inhibitor, which reduces the activity of melanocytes by blocking the interaction between melanocytes and keratinocytes. Kojic acid and arbutin serve as tyrosinase inhibitors, preventing the enzymatic conversion of tyrosine to melanin. Magnesium ascorbyl phosphate provides additional tyrosinase inhibition and antioxidant protection, while Vitamin E acts as a skin-conditioning agent. The **Melano TX Tablet** typically contains tranexamic acid as the primary active ingredient, sometimes in combination with antioxidants like proanthocyanidins, to manage systemic factors contributing to melasma.

Brand names
Melano TXMelano TX CreamMelano TX Tablet
Other names
Melano-TX
02

Targets

TYR (Tyrosinase)PLG (Plasminogen)

Beyond the preview

Go deeper on Melano TX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melano TX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call